 growth asthmat children treatment budesonid doubl blind trial object inhal glucocorticosteroid budesonid advers effect short term linear growth children mild asthma set outpati clinic secondari referr centr patient children year normal statur growth veloc previou year sign puberti use system topic steroid month studi design OF intervent doubl blind crossov trial activ period budesonid divid daili dose microgram microgram run washout period placebo second washout period children open treatment microgram budesonid period day durat main outcom measur growth leg week knemometri result mean growth veloc leg mm/week washout mm/week budesonid treatment signific dose reduct growth veloc mean reduct growth veloc treatment confid interv mm/week microgram page test treatment microgram reduct mm/week conclus treatment inhal budesonid dose relat suppress short term linear growth children mild asthma